Remedy Pharmaceuticals jobs and careers
New York, NY, United States
About Remedy Pharmaceuticals
Remedy Pharmaceuticals, Inc. develops small molecule drugs that target NCCa-ATP channels in acute central nervous system injuries, including traumatic brain injuries, strokes, and spinal cord injuries. Its RP-1127 is an intravenous version of glyburide, an inhibitor of NCCa-ATP channels that acts through antagonism of the type-1 sulfonylureareceptor. The company was founded in 2004 and is based in New York, New York.
Founded in 2004 by David M. Geliebter and Sven M. Jacobson.
- Founded
- 2004
- Employees
- 11 to 50
- Total funding
- $18.5M
- Headquarters
- New York
Leadership
The top of Remedy Pharmaceuticals's org chart, with how many people report into each leader.
Sven Jacobson
CEO/Cofounder
2 reports
Thomas MacAllister, JD, PhD
Vice President of R&D and General Counsel
Ann Tunstall
Vice President, Regulatory and Clinical Operations
Jobs at Remedy Pharmaceuticals
No open positions right now. Explore more companies on TheJobsMap.